Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cytokine therapy]

P Maruna1, Z Masek

  • 1III. interní klinika 1. LF UK a VFN, Praha.

Casopis Lekaru Ceskych
|January 18, 1995
PubMed
Summary

Cytokines are emerging as a new class of therapeutics for various diseases, including cancers and blood disorders. While promising, their clinical application is limited by toxicity and cost, necessitating combination therapies and novel administration routes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomised controlled trial of roller versus centrifugal cardiopulmonary bypass pumps in patients undergoing pulmonary endarterectomy.

Perfusion·2014
Same author

Aprotinin reduces the procalcitonin rise associated with complex cardiac surgery and cardiopulmonary bypass.

Physiological research·2012
Same author

Plasma hepcidin correlates positively with interleukin-6 in patients undergoing pulmonary endarterectomy.

Physiological research·2011
Same author

Disturbances of gastric electrical control activity after laparotomic cholecystectomy are related to interleukin-6 concentrations.

European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes·2009
Same author

Thrombophilia and pulmonary endarterectomy.

Prague medical report·2009
Same author

Quantitative analysis of procalcitonin after pulmonary endarterectomy in relation to cytokines and C-reactive protein.

Prague medical report·2009

Area of Science:

  • Biotechnology
  • Immunology
  • Pharmacology

Context:

  • Cytokines, crucial intercellular mediators, are increasingly utilized in hematology, oncology, and immunology.
  • Current applications focus on treating leukemias, advanced solid tumors, and impaired hematopoiesis.

Purpose:

  • To explore the expanding clinical applications of cytokines in various medical disciplines.
  • To discuss the potential of cytokines in treating viral diseases, immunodeficiencies, and systemic sclerosis.

Summary:

  • Cytokines like interferons and interleukins show promise in treating hematological malignancies and solid tumors.
  • Erythropoietin and colony-stimulating factors are established treatments for impaired hematopoiesis.
  • Future applications may include treating viral infections, immunodeficiencies, and systemic sclerosis, often in combination with conventional therapies.

Impact:

  • Cytokine therapy, particularly in oncology, is shifting towards combination approaches rather than monotherapy.
  • Significant toxicity and cost are key limitations, driving research into alternative administration methods like local or compartmental delivery.

Related Experiment Videos